Gujarat Themis Biosyn Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 18.07% vs -4.95% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 57.40% vs -24.50% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 50.61% vs -13.28% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -42.86% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Guj. Themis Bio. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

42.35

7.86

34.49

438.80%

Other Operating Income

0.00

Total Operating income

42.35

7.86

34.49

438.80%

Raw Material Cost

6.92

6.10

0.82

13.44%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-1.53

0.00

-1.53

Employee Cost

4.85

26.19

-21.34

-81.48%

Power Cost

6.94

0.00

6.94

Manufacturing Expenses

2.04

8.01

-5.97

-74.53%

Selling and Distribution Expenses

0.00

22.42

-22.42

-100.00%

Other Expenses

2.18

11.03

-8.85

-80.24%

Total Expenditure (Excl Depreciation)

21.40

73.75

-52.35

-70.98%

Operating Profit (PBDIT) excl Other Income

20.95

-65.89

86.84

131.80%

Other Income

0.82

0.01

0.81

8,100.00%

Operating Profit (PBDIT)

21.77

-65.88

87.65

133.04%

Interest

0.04

7.52

-7.48

-99.47%

Exceptional Items

0.00

Gross Profit (PBDT)

21.73

-73.40

95.13

129.60%

Depreciation

2.96

2.57

0.39

15.18%

Profit Before Tax

18.76

-75.97

94.73

124.69%

Tax

4.50

0.00

4.50

Provisions and contingencies

0.00

Profit After Tax

14.26

-75.97

90.23

118.77%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

14.26

-75.97

90.23

118.77%

Equity Capital

10.90

32.45

-21.55

-66.41%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.31

-2.34

3.65

155.98%

Diluted Earnings per share

1.31

-2.34

3.65

155.98%

Operating Profit Margin (Excl OI)

49.47%

-838.30%

0.00

887.77%

Gross Profit Margin

51.31%

-933.84%

0.00

985.15%

PAT Margin

33.67%

-966.54%

0.00

1,000.21%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 42.35 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 18.07% vs -4.95% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 21.98% vs -12.19% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 14.26 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 57.40% vs -24.50% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 34.91% vs -15.71% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 20.95 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 50.61% vs -13.28% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 36.04% vs -7.89% in Sep 2024

Quarterly - Interest

Interest 0.04 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -42.86% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -50.00% vs 60.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 49.47%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024